Priti Patel

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib”.

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Blood(2020)10.1182/blood.2019003715

N/A

3.3DataRank · unranked

106 citations

Pia Nierman, Ellen K. Kendall, Jean Cheung, Michael Gulrajani, Sarah E. M. Herman +16 more

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

Journal of Hematology & Oncology(2021)10.1186/s13045-020-01004-y

N/A

1.9DataRank · unranked

86 citations

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Tadeusz Robak +14 more

Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3505

N/A

1.7DataRank · unranked

31 citations

Jean Cheung, Michael Gulrajani, Erika M. Gaglione, Pia Nierman, Ahmed Hamdy +8 more

Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses

Neuro-Oncology(2020)10.1093/neuonc/noaa006

N/A

0DataRank · unranked

50 citations

Patrick Dunn, Anna E. Argento, Padma Kadiyala, Maria Ventosa, Priti Patel +6 more

A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer

Cancer(2020)10.1002/cncr.33067

N/A

0DataRank · unranked

35 citations

Michael R. Harrison, Peter H. O’Donnell, Ajjai Alva, Noah M. Hahn, Leonard J. Appleman +17 more

Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2547

N/A

0DataRank · unranked

29 citations

Courtney B. Betts, Lauren Maloney, Eric Nadler, Alain P. Algazi, Michael J. Guarino +10 more